Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Type 2 Diabetes Path to Remission Programme to be rolled out across England

Type 2 Diabetes Path to Remission Programme to be rolled out across England

Over 1,150 people with type 2 diabetes and obesity or overweight in the West Midlands have benefited from this programme

NHS England is expanding the Type 2 Diabetes Path to Remission Programme across the country from April 2024, following the successful pilot launch in the Midlands.


A joint initiative between NHSE and Diabetes UK, the programme offers a low calorie, total diet replacement treatment for individuals who are living with type 2 diabetes and obesity or overweight.

More than 1,150 patients in the West Midlands have joined the programme and benefited from it since its introduction in 2020 until February 2024.

Previously known as the NHS Low Calorie Diet Programme, this evidence-based intervention is aimed at reversing diabetes and maintaining weight loss in the long term.

“This is such a great chance for people to take control of their health and to put their type 2 diabetes into remission,” said Professor Vinod Patel, West Midlands Clinical Lead for NHS England (Midlands) for Diabetes.

Peter Shorrick, head of Midlands and East at Diabetes UK, explained that achieving remission can help reduce the risk of developing serious problems with the eyes, feet, or heart in many patients with type 2 diabetes, while also providing hope for a medication-free future.

“People in remission say it’s life changing and we funded research that shows that this programme works.

“Our aim is to support people to go on the Path to Remission Programme and achieve results safely, complementing it with our advice on a range of issues from maintaining a healthy diet, to exercise, mental health and the importance of peer-to-peer support to provide a holistic approach,” he added.

This programme is based on research that found a 3-month specially formulated ‘soup and shake’ diet, coupled with healthy lifestyle support, helped people living with type 2 diabetes and obesity or overweight to lose over 10kg (1st  5lbs) in weight, improve their blood glucose levels, reduce diabetes-related medication and achieve remission of type 2 diabetes in almost half of the participants.

People aged 18 – 65 years who have been diagnosed with type 2 diabetes within the last six years, and have a BMI over 27 kg/m2 (for individuals from White ethnic groups) or over 25 kg/m2 (for individuals from Black, Asian and other ethnic groups) are eligible to participate in the NHS Type 2 Diabetes Path to Remission Programme.

James from Birmingham has lost 95kg (54 per cent of his body weight) since starting the programme in 2021.

“I now weigh 82kg. With a Hb1Ac (average blood glucose) of 29, my diabetes is in remission and my GP has advised me that I don’t need any diabetes treatment which is fantastic,” James said.

He was referred to the programme by a nurse practitioner from his GP surgery due to difficulties tolerating his medications. At that time, his weight was 177kg (27st 8 lbs).

More For You

Call to improve inclusivity in clinical research

Ethnic minority adults continue to be underrepresented in clinical trials.

iStock

Call to improve inclusivity in clinical research

A NEW report has called for the participation of a wide range of diverse communities in clinical research to make sure that the medicines meet the needs of the UK's increasingly diverse population.

The report ‘Achieving inclusivity in clinical research’, prepared by the Association of the British Pharmaceutical Industry (ABPI) and the Association of Medical Research Charities (AMRC), highlights the long-standing challenges in ensuring diversity in clinical trials.

Keep ReadingShow less
Pharmacy students Learning Support Fund

Pharmacy students will be included in the Travel and Dual Accommodation Expenses section of the NHS Learning Support Fund.

iStock

Pharmacy students to have access to Learning Support Fund

FOR the first time in England, pharmacy students will be eligible to reimburse travel and accommodation costs while attending placements.

The Department of Health and Social Care confirmed that pharmacy students would finally be included in the Travel and Dual Accommodation Expenses (TDAE) section of the NHS Learning Support Fund (LSF).

Keep ReadingShow less
NHS for robotic surgery

Patients undergoing robotic surgery are able to recover quicker and be discharged sooner.

Pic credit: iStock

NHS pushes for robotic surgery to reduce waiting time, improve outcomes

The NHS is planning to step up robotic surgery over the next decade to reduce waiting time, help in the speed of recovery of patients, and shorter hospital stay.

As per the NHS projections, the number is expected to zoom from 70,000 in 2023/24 to half a million by 2035.

Keep ReadingShow less
Scotland's digital patient care record

The amendment ensures that every person who receives health care or a social service in Scotland will have a digital care record

Pic credit: iStock

Scotland's move to create digital patient care record hailed

The Royal Pharmaceutical Society (RPS) in Scotland has welcomed the decision of the Scottish Parliament to create an integrated digital patient care record.

The move came during a debate on the Care Reform (Scotland) Bill on Tuesday (10), when Jackie Baillie tabled an amendment to ensure that every person who receives health care or a social service in Scotland has a digital care record.

Keep ReadingShow less
A woman using a period tracker app

Cambridge University academics have flagged concerns over the safety of period tracker apps

Pic credit: iStock

Users of period tracking apps face privacy, safety risk, say experts

The report said the apps provide a "gold mine" of data for consumer profiling and warn that in the wrong hands it could pose a safety risk

CAMBRIDGE UNIVERSITY academics have flagged concerns over the safety of period tracker apps and warned that the women using them could face privacy and safety risks.

Keep ReadingShow less